Beyond Ozempic: The GLP-1 Boom
from Mayo Clinic Health Matters Hosted by Mayo Clinic Press
Ozempic. Wegovy. Mounjaro. Zepbound. You’ve probably heard the name of one of these drugs in the past few years—maybe you’ve even thought about taking them. Every day, more Americans are taking these drugs known as GLP-1s, either for chronic conditions like diabetes or, increasingly, for weight loss. So do these drugs deliver on the promise of easy weight loss? And are they right for everyone? This episode, we talk with Mayo Clinic dietitian and host of Mayo Clinic On Nutrition Tara Schmidt about the drugs that have taken weight loss culture by storm. Find us online at Mayo Clinic Press for more health and wellness articles, podcasts and books. Do you have feedback, questions or topic suggestions? Email us at [email protected].
Embed this episode
No transcript yet.